Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Assets
Cash
Due from related party
Prepaid expenses
Deferred offering costs
Total current assets
Prepaid expenses, non-current
Marketable securities held in Trust Account
Total Assets
Accrued offering costs and expenses
Due to related parties
Promissory note – related party
Accounts payable and accrued expenses
Liabilities, Redeemable Common Stock, and Stockholders’ Deficit
Accounts payable and accrued expenses
Due to related party
Income tax payable
Convertible promissory note – related party
Total current liabilities
Warrant liability
Deferred underwriting fees
Total liabilities
Class A common stock subject to possible redemption, 25,875,000 shares at redemption value at September 30, 2022 and December 31, 2021
Stockholders’ Deficit
Class A common stock, $0.0001 par value; 200,000,000 shares authorized, no shares issued and outstanding at September 30, 2022 and December 31, 2021, excluding 25,875,000 shares subject to possible redemption
Class B common stock, $0.0001 par value; 20,000,000 shares authorized, 6,468,750 shares issued and outstanding
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,468,750 shares issued and outstanding at September 30, 2022 and December 31, 2021
Additional paid-in capital
Accumulated deficit
Total stockholders’ deficit
Total Liabilities, Redeemable Common Stock, and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support